Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|May 29, 2001
Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorptionP J Kostenuik, V Shalhoub
Clinical & Experimental Metastasis|January 1, 1997
Transforming growth factor beta upregulates the integrin-mediated adhesion of human prostatic carcinoma cells to type I collagenP J Kostenuik, G Singh, F W Orr
Cancer Research|November 15, 1993
Increased growth rate and tumor burden of spontaneously metastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated ratsP J Kostenuik, F W Orr, K Suyama, et al.
Clinical & Experimental Metastasis|November 1, 1992
A quantitative model for spontaneous bone metastasis: evidence for a mitogenic effect of bone on Walker 256 cancer cellsP J Kostenuik, G Singh, K L Suyama, et al.
Clinical & Experimental Metastasis|November 1, 1992
Stimulation of bone resorption results in a selective increase in the growth rate of spontaneously metastatic Walker 256 cancer cells in boneP J Kostenuik, G Singh, K L Suyama, et al.
Clinical & Experimental Metastasis|January 1, 1996
Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the alpha 2 beta 1 integrinP J Kostenuik, O Sanchez-Sweatman, F W Orr, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|July 11, 2003
Selective adhesion of osteoblastic cells to different integrin ligands induces osteopontin gene expressionR S Carvalho, P J Kostenuik, E Salih, et al.
The American Journal of Physiology|January 22, 1998
Skeletal unloading inhibits the in vitro proliferation and differentiation of rat osteoprogenitor cellsP J Kostenuik, B P Halloran, E R Morey-Holton, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 27, 2007
The RANKL inhibitor OPG-Fc increases cortical and trabecular bone mass in young gonad-intact cynomolgus monkeysM S Ominsky, P J Kostenuik, P Cranmer, et al.
Cancer Research|June 5, 2001
Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasisS Morony, C Capparelli, I Sarosi, et al.
Pageof 3